C0040541||toxicology
C0013125||intravenous administration
C0540511||angiopoietin�€‘2
C1099354||siRNA
C0032136||plasmid
C0162969||chitosan
C2713587||magnetic nanoparticles
C2603343||study
C0040541||toxicology
C0013125||intravenous administration
C0540511||angiopoietin�€‘2
C0540511||angiopoietin�€‘2
C1099354||small interfering (si)RNA
C0032136||plasmid
C0162969||chitosan
C2713587||magnetic nanoparticles
C2713587||chitosan magnetic nanoparticles
C0540511||angiopoietin�€‘2
C2713587||chitosan magnetic nanoparticles
C0025929||mice
C0034693||rats
C2985205||tail vein
C0025929||mice
C0600688||toxicity
C0034693||rats
C0022885||toxicity assay
C0025929||mice
C1142435||general condition
C0025929||mice
C3809765||no obvious abnormalities
C0242073||partial lung congestion
C3809765||no obvious abnormalities
C0022885||toxicity assay
C0540511||angiopoietin�€‘2
C2713587||chitosan magnetic nanoparticles
C0034693||rat
C0034693||rat
C1142435||general condition
C3809765||no obvious abnormality
C0022885||blood routine indexes
C1261161||lung/body ratio
C0242073||pulmonary congestion
C3809765||no abnormality
C0003055||organs
C3809765||no obvious abnormality
C0540511||angiopoietin�€‘2
C2713587||chitosan magnetic nanoparticles
C0013161||drug carrier